使用临床医生控制的远程康复系统在全膝关节置换术后为医疗保险患者带来显著成本节约和早期临床结局改善
本研究对比了109例接受标准物理治疗(SPT)的医疗保险患者与101例接受临床医生控制的远程康复家庭系统(HCTS)的医疗保险患者。HCTS组平均康复成本显著更低,膝关节活动度改善更快且持续,术后各评估点的VAS疼痛评分和KOOS-JR功能评分均显著优于SPT组(均P<.001)并超过最小临床重要差异阈值。HCTS每例患者相比标准治疗节约2,460美元。
要点
- HCTS组平均康复成本显著低于SPT组,每例患者节约2,460美元。
- HCTS组膝关节活动度改善更快且持续,术后各时间点VAS疼痛和KOOS-JR评分均显著优于SPT组(均P<.001)。
核心结论
- 本研究中使用的HCTS相比标准治疗每例患者节约2,460美元,且功能结局和疼痛评分在所有评估时间点均更优并超过最小临床重要差异。
研究设计与样本
- 前瞻性入组的连续109例接受SPT的医疗保险患者与101例接受HCTS的医疗保险患者进行比较,分析总康复成本和结局指标(膝关节活动度、VAS疼痛评分、KOOS-JR)。
主要发现
- HCTS组平均康复成本显著低于SPT组。
- HCTS组膝关节活动度改善更快且持续。
- HCTS组术后所有评估点的VAS疼痛评分和KOOS-JR功能评分均显著优于SPT组(均P<.001),且超过最小临床重要差异阈值。
- HCTS相比标准治疗每例患者节约2,460美元。
关键数值与推荐
- HCTS组与SPT组在术后所有评估点的VAS疼痛评分和KOOS-JR功能评分差异均P<.001。
- HCTS相比标准治疗每例患者节约2,460美元。
临床怎么用
- 原文结论指出HCTS在本研究中显示出成本节约优势,且HCTS队列功能结局和疼痛评分更优。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The costs and benefits of different rehabilitation protocols following total knee arthroplasty are unclear. The emergence of telerehabilitation has introduced the potential for enhanced patient convenience and cost reduction. The purpose of this study was to assess the cost difference between standard physical therapy (SPT) and a telerehabilitation home-based clinician-controlled therapy system (HCTS). METHODS: A prospectively enrolled, consecutive series of 109 Medicare patients who received SPT were compared to 101 Medicare patients who were treated with a HCTS. The analysis focused on total rehabilitation costs and the assessment of outcome measures: knee range of motion, visual analog scale pain levels, and Knee Injury and Osteoarthritis Outcome Score for Joint Replacement. RESULTS: The HCTS group demonstrated not only statistically significantly lower average costs but also faster and sustained knee range of motion improvements. Furthermore, in comparison to SPT, the HCTS group exhibited superior visual analog scale pain scores and Knee Injury and Osteoarthritis Outcome Score for Joint Replacement functional scores at all assessment points postoperatively, which were statistically significant (all P < .001) and surpassed the minimal clinically important difference thresholds. CONCLUSIONS: The HCTS used in this study exhibited a remarkable cost-saving advantage of $2,460 per patient compared to standard therapy. As approximately 500,000 primary total knee arthroplasties in the United States are covered by Medicare annually, a switch to HCTS could yield total cost savings of more than $1.23 billion per year for our taxpayer-funded health care system. Furthermore, the HCTS cohort demonstrated superior functional outcomes and improved pain scores across all assessment time points, exceeding the minimal clinically important difference.
引用
- Summers SH, Gnecco T, Slotkin EM, et al. Significant Cost Savings and Improved Early Clinical Outcomes in Medicare Patients Utilizing a Clinician-Controlled Telerehabilitation System Following Total Knee Arthroplasty. J Arthroplasty. 2024. PMID: 38401615. doi:10.1016/j.arth.2024.02.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。